We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AKTX

Price
1.12
Stock movement down
-0.03 (-2.61%)
Company name
Akari Therapeutics PLC
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
36.53M
Ent value
43.71M
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-37.14%
1 year return
-62.16%
3 year return
-61.60%
5 year return
-52.35%
10 year return
-38.64%
Last updated: 2025-08-27

iO Charts is a Seeking Alpha partner

DIVIDENDS

AKTX does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count32.61M
EPS (TTM)-1.60
FCF per share (TTM)-0.86

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-13.00K
Operating income (TTM)-20.16M
Net income (TTM)-19.52M
EPS (TTM)-1.60
EPS (1y forward)-0.40

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.25M
Net receivables0.00
Total current assets2.73M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.73M
Accounts payable4.78M
Short/Current long term debt1.00M
Total current liabilities9.43M
Total liabilities9.43M
Shareholder's equity-6.69M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-10.43M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-10.43M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-714.11%
Return on Invested Capital342.88%
Cash Return on Invested Capital183.20%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.20
Daily high1.22
Daily low1.09
Daily Volume28K
All-time high5000.00
1y analyst estimate6.00
Beta0.23
EPS (TTM)-1.60
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AKTXS&P500
Current price drop from All-time high-99.98%-3.04%
Highest price drop-99.98%-56.47%
Date of highest drop28 Feb 20259 Mar 2009
Avg drop from high-96.23%-11.04%
Avg time to new high1409 days12 days
Max time to new high2817 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
AKTX (Akari Therapeutics PLC) company logo
Marketcap
36.53M
Marketcap category
Small-cap
Description
Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads include PH5, which inhibits DNA mismatch repair (MMR) and DNA damage response (DDR) to generate neoepitopes, and PH6, which inhibits DNA transcription in cancer cells and co-opted immune cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Boston, Massachusetts.
Employees
8
Investor relations
-
SEC filings
CEO
Clive Stuart Richardson
Country
USA
City
London
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...